echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > PNAS: Identifying insulin immune responses can be used to identify people with type 1 diabetes

    PNAS: Identifying insulin immune responses can be used to identify people with type 1 diabetes

    • Last Update: 2021-02-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    February 9, 2021 /--- -- Researchers at the Center for Childhood Diabetes at the University of Colorado School of Medicine have found that an immune response to insulin can help identify patients most likely to develop type 1 diabetes.
    study, published recently in the journal PNAS, measured the immune response of genetically prediscent type 1 diabetic individuals to naturally occurring insulin and hybrid insulin peptides.
    because not all individuals with genetic susceptible people have type 1 diabetes, the researchers tried to examine the immune response of exocytocytes that may occur before the onset of clinical diabetes.
    (Photo: www.pixabay.com) "We wanted to know why people develop type 1 diabetes, and this study helps provide more information and data on how individuals at genetic risk are moving toward clinical diagnosis," said Dr. Aaron Michels, who led the study.
    ideally, patients want to treat the disease when it is active, so this is how we need to know when people in the field have an immune response to insulin-producing cells.
    " researchers collect blood samples from adolescents at genetic risk every six months for two years.
    reactions to mixed insulin peptides were associated with worsening blood sugar measurements and the development of type 1 diabetes.
    results show that important progress has been made in identifying the risk of type 1 diabetes early and the potential for intervention.
    the treatment used in the study has delayed the onset of clinical type 1 diabetes," said Michelle Mitchell, a researcher at the University of New China.
    patients with these specific immune responses may benefit from immunological interventions to delay the onset of type 1 diabetes and may prevent it for years.
    , Michels said, these results could lead to more studies than type 1 diabetes.
    s focus is on diabetes, but it has implications for other autoimmune diseases," he said.
    understanding the immune system's response is critical to trying to prevent disease before clinical symptoms appear.
    " (Bioon.com) Source: Immune response to insulin can identify, help treat those at risk for type 1 diabetes Original source: Angela M. Mitchell et al. T-cell responses to hybrid insulin peptides prior to type 1 diabetes development, Proceedings of the National Academy of Sciences (2021). DOI: 10.1073/pnas.2019129118
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.